Pharmacopeia

CWP-0140

KETAMINE

Neurology & Sedation · Neurology & Sedation · Level 1

Core pharmacology

Legacy Cicm Level

Level 1

Introduction

Phencyclidine (remember the street drug name PCP) derivative that
produces dissociative anesthesia

Indications Uses

Induction of anaesthesia
- Procedural sedation
- Analgesia
- ?Role in management of depression. - Recreational

Presentation

10, 50 or 100mg/ml

Mechanism of action

NMDA receptor antagonism
- Inhibits excitatory signaling within CNS
- Also inhibits noradrenaline reuptake in sympathetic nerve terminals

Physiological effects

CNS: Causes dissociative anaesthesia
- Hallucinations
- Emergence delirium

CVS: Indirect sympathomimetic
chronotropy, inotrophy and Hypertension
Direct cardiodepressant
 if depletion of NA  hypotension
Resp - Bronchodilation

Adverse Effects Toxicity

Increased salivation - Upper airway reflexes intact  laryngospasm - Hypotension if given in shock states - Emergence delirium

Absorption

A: 20% oral bioavailability

Protein binding

25%

Volume of distribution

3l/kg

Metabolism

Hepatic metabolism with active
norketamine metabolite

Excretion

Renal elimination

Half-life

T1/2a 15 mins, T1/2b
2~3 hours, CSHT 40mins at 5 hours

Route And Dose

- 1mg/kg induction dose
- 10~20mg analgesia

Additional pharmacology

Class Group

Non-Opiate Analgesic

Neurology & Sedation · Neurology & Sedation

Class Group

Sedative / Hypnotic